Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna Sf Lok

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Current Opinion in Gastroenterology|April 7, 2007
Update on viral hepatitis: 2006Jessica Tan, Anna Sf Lok
Current Opinion in Gastroenterology|April 15, 2008
Update on viral hepatitis: 2007Bulent Degertekin, Anna Sf Lok
Antiviral Research|November 30, 2025
Update on combination therapies against HBV in clinical investigationsLung-Yi Mak, Anna Sf Lok
Hepatology Communications|September 27, 2023
Regional changes in intestinal permeability in cirrhosis are associated with mucosal bacteriaPatricia P Bloom, Krishna Rao, Christine Bassis, et al.
The American Journal of Gastroenterology|January 28, 2010
Cognitive function does not worsen during long-term low-dose peginterferon therapy in patients with chronic hepatitis CRobert J Fontana, Linas A Bieliauskas, Carla Back-Madruga, et al.
Hepatology (Baltimore, Md.)|August 3, 2018
ReplyNorah A Terrault, Robert S Brown, Anna Sf Lok, et al.
Hepatology (Baltimore, Md.)|April 19, 2023
Use of HBV RNA and to predict change in serological status and disease activity in CHBMarc G Ghany, Wendy C King, Amanda S Hinerman, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Current Opinion in Gastroenterology|April 7, 2007
Update on viral hepatitis: 2006Jessica Tan, Anna Sf Lok
Current Opinion in Gastroenterology|April 15, 2008
Update on viral hepatitis: 2007Bulent Degertekin, Anna Sf Lok
Antiviral Research|November 30, 2025
Update on combination therapies against HBV in clinical investigationsLung-Yi Mak, Anna Sf Lok
Hepatology Communications|September 27, 2023
Regional changes in intestinal permeability in cirrhosis are associated with mucosal bacteriaPatricia P Bloom, Krishna Rao, Christine Bassis, et al.
The American Journal of Gastroenterology|January 28, 2010
Cognitive function does not worsen during long-term low-dose peginterferon therapy in patients with chronic hepatitis CRobert J Fontana, Linas A Bieliauskas, Carla Back-Madruga, et al.
Hepatology (Baltimore, Md.)|August 3, 2018
ReplyNorah A Terrault, Robert S Brown, Anna Sf Lok, et al.
Hepatology (Baltimore, Md.)|April 19, 2023
Use of HBV RNA and to predict change in serological status and disease activity in CHBMarc G Ghany, Wendy C King, Amanda S Hinerman, et al.
Pageof 1